Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fish and Richardson
Baxter
Cerilliant
Merck
Covington
Johnson and Johnson
QuintilesIMS
Dow
Chubb

Generated: April 20, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 022548

« Back to Dashboard

NDA 022548 describes ZYMAXID, which is a drug marketed by Allergan and is included in one NDA. It is available from three suppliers. Additional details are available on the ZYMAXID profile page.

The generic ingredient in ZYMAXID is gatifloxacin. There are sixteen drug master file entries for this compound. Seven suppliers are listed for this compound. Additional details are available on the gatifloxacin profile page.
Summary for 022548
Tradename:ZYMAXID
Applicant:Allergan
Ingredient:gatifloxacin
Patents:0
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Pharmacology for NDA: 022548
Ingredient-typeQuinolones
Suppliers and Packaging for NDA: 022548
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ZYMAXID gatifloxacin SOLUTION/DROPS;OPHTHALMIC 022548 NDA Allergan, Inc. 0023-3615 N 0023-3615-25
ZYMAXID gatifloxacin SOLUTION/DROPS;OPHTHALMIC 022548 NDA Allergan, Inc. 0023-3615 N 0023-3615-01

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:SOLUTION/DROPS;OPHTHALMICStrength0.5%
Approval Date:May 18, 2010TE:ATRLD:Yes

Expired US Patents for NDA 022548

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Allergan ZYMAXID gatifloxacin SOLUTION/DROPS;OPHTHALMIC 022548-001 May 18, 2010 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Dow
Fish and Richardson
Chinese Patent Office
QuintilesIMS
Chubb
Healthtrust
Johnson and Johnson
Harvard Business School
US Department of Justice

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.